This study investigates advanced pancreatic cancer. It looks at how well a treatment works when combined with other medications.
The study evaluates the safety and effectiveness of the investigational medication when used with oxaliplatin and 5-FU/LV. It compares this to another treatment to see which works better.
- Who can participate: Adults with advanced pancreatic cancer who have not received previous treatment for metastatic disease can participate. They must have a good performance status and a life expectancy of at least 3 months.
- Study details: Participants will receive an investigational medication with other drugs to see how well it works. Some participants may receive a placebo.